Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/53182
COMPARTIR / EXPORTAR:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis

AutorTeruel, María; Simeón, Carmen P.; Broen, Jasper C.; Vonk, Madelon C.; Carreira, P.; Camps, M. T.; García-Portales, Rosa; Delgado-Frías, Esmeralda; Gallego, María; Espinosa, Gerard; Spanish Scleroderma Group; Beretta, L.; Airó, Paolo; Lunardi, C.; Riemekasten, G.; Witte, Torsten; Krieg, Thomas; Kreuter, A.; Distler, J. H.; Hunzelmann, Nicolas; Koeleman, B. P.; Voskuyl, Alexandre E.; Schuerwegh, A. J.; González-Gay, M. A.; Radstake, T. R.; Martín, J.
Fecha de publicación25-jun-2012
EditorBioMed Central
CitaciónArthritis Research & Therapy 14(3) : R154- (2012)
ResumenAbstract Introduction The aim of the present study was to investigate the possible role of CD40 and CD40 ligand (CD40LG) genes in the susceptibility and phenotype expression of systemic sclerosis (SSc). Methods In total, 2,670 SSc patients and 3,245 healthy individuals from four European populations (Spain, Germany, The Netherlands, and Italy) were included in the study. Five single-nucleotide polymorphisms (SNPs) of CD40 (rs1883832, rs4810485, rs1535045) and CD40LG (rs3092952, rs3092920) were genotyped by using a predesigned TaqMan allele-discrimination assay technology. Meta-analysis was assessed to determine whether an association exists between the genetic variants and SSc or its main clinical subtypes. Results No evidence of association between CD40 and CD40LG genes variants and susceptibility to SSc was observed. Similarly, no significant statistical differences were observed when SSc patients were stratified by the clinical subtypes, the serologic features, and pulmonary fibrosis. Conclusions Our results do not suggest an important role of CD40 and CD40LG gene polymorphisms in the susceptibility to or clinical expression of SSc.
URIhttp://hdl.handle.net/10261/53182
Identificadoreshttp://dx.doi.org/10.1186/ar3890
Aparece en las colecciones: (IPBLN) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
ar3890.xml78,9 kBXMLVisualizar/Abrir
ar3890.pdf175,48 kBAdobe PDFVista previa
Visualizar/Abrir
AR3890-S1.DOC323 kBMicrosoft WordVisualizar/Abrir
Mostrar el registro completo

CORE Recommender

Page view(s)

461
checked on 18-mar-2024

Download(s)

677
checked on 18-mar-2024

Google ScholarTM

Check


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.